Marksans Pharma
FDA Approved Drugs

Marksans Pharma

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

OTC RX
  • Total Records 38
  • Latest Approval Date Mar 30, 2026
  • Data Source FDA
  • First Approval Date Aug 02, 2001
All
38
View
OTC
19
View
RX
19
View
Company Overview

Company

Marksans Pharma

Country

India

Website

Visit Website

Email

info@marksanspharma.com

Social Profiles

Company Snapshot

Marksans Pharma

1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Near Keys Hotel, Marol, Andheri (East), Mumbai – 400059, Maharashtra

India

marksanspharma.com/ info@marksanspharma.com View on Map
FDA Approved Drug Records ( 38 records )
2021
25 Aug
OTC Application: 215486

Drug Name

ACETAMINOPHEN

Product Number

1

Dosage Form

-

Strength

650MG

Approval Date

2021-08-25

215486 / 1

Active Ingredient

ACETAMINOPHEN

Application Number

215486

Product Number

1

Dosage Form

-

Strength

650MG

Approval Date

2021-08-25

Regulatory Status

OTC

2023
10 Jul
OTC Application: 216994

Drug Name

ACETAMINOPHEN AND IBUPROFEN

Product Number

1

Dosage Form

-

Strength

250MG;125MG

Approval Date

2023-07-10

216994 / 1

Active Ingredient

ACETAMINOPHEN; IBUPROFEN

Application Number

216994

Product Number

1

Dosage Form

-

Strength

250MG;125MG

Approval Date

2023-07-10

Regulatory Status

OTC

2026
30 Mar
RX Application: 220298

Drug Name

BENZONATATE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-03-30

220298 / 1

Active Ingredient

BENZONATATE

Application Number

220298

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-03-30

Regulatory Status

RX

2026
30 Mar
RX Application: 220298

Drug Name

BENZONATATE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2026-03-30

220298 / 2

Active Ingredient

BENZONATATE

Application Number

220298

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2026-03-30

Regulatory Status

RX

2010
15 Jun
OTC Application: 78933

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2010-06-15

78933 / 1

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78933

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2010-06-15

Regulatory Status

OTC

2010
15 Jun
OTC Application: 78933

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2010-06-15

78933 / 2

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78933

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2010-06-15

Regulatory Status

OTC

2010
15 Jun
OTC Application: 78933

Drug Name

CETIRIZINE HYDROCHLORIDE HIVES

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2010-06-15

78933 / 3

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78933

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2010-06-15

Regulatory Status

OTC

2010
15 Jun
OTC Application: 78933

Drug Name

CETIRIZINE HYDROCHLORIDE HIVES

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2010-06-15

78933 / 4

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78933

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2010-06-15

Regulatory Status

OTC

2023
29 Sep
OTC Application: 217264

Drug Name

ESOMEPRAZOLE MAGNESIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2023-09-29

217264 / 1

Active Ingredient

ESOMEPRAZOLE MAGNESIUM

Application Number

217264

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2023-09-29

Regulatory Status

OTC

2023
08 Mar
OTC Application: 217543

Drug Name

FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-03-08

217543 / 1

Active Ingredient

FAMOTIDINE

Application Number

217543

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-03-08

Regulatory Status

OTC

2023
08 Mar
OTC Application: 217543

Drug Name

FAMOTIDINE

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-03-08

217543 / 2

Active Ingredient

FAMOTIDINE

Application Number

217543

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-03-08

Regulatory Status

OTC

2002
29 Jan
RX Application: 75465

Drug Name

FLUOXETINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2002-01-29

75465 / 1

Active Ingredient

FLUOXETINE HYDROCHLORIDE

Application Number

75465

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2002-01-29

Regulatory Status

RX

2002
29 Jan
RX Application: 75465

Drug Name

FLUOXETINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2002-01-29

75465 / 2

Active Ingredient

FLUOXETINE HYDROCHLORIDE

Application Number

75465

Product Number

2

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2002-01-29

Regulatory Status

RX

2001
02 Aug
RX Application: 75465

Drug Name

FLUOXETINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2001-08-02

75465 / 3

Active Ingredient

FLUOXETINE HYDROCHLORIDE

Application Number

75465

Product Number

3

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2001-08-02

Regulatory Status

RX

2011
21 Jul
RX Application: 90007

Drug Name

GABAPENTIN

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2011-07-21

90007 / 1

Active Ingredient

GABAPENTIN

Application Number

90007

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2011-07-21

Regulatory Status

RX

2011
21 Jul
RX Application: 90007

Drug Name

GABAPENTIN

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2011-07-21

90007 / 2

Active Ingredient

GABAPENTIN

Application Number

90007

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2011-07-21

Regulatory Status

RX

2011
21 Jul
RX Application: 90007

Drug Name

GABAPENTIN

Product Number

3

Dosage Form

-

Strength

400MG

Approval Date

2011-07-21

90007 / 3

Active Ingredient

GABAPENTIN

Application Number

90007

Product Number

3

Dosage Form

-

Strength

400MG

Approval Date

2011-07-21

Regulatory Status

RX

2023
21 Aug
OTC Application: 217780

Drug Name

GUAIFENESIN

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2023-08-21

217780 / 1

Active Ingredient

GUAIFENESIN

Application Number

217780

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

2023-08-21

Regulatory Status

OTC

2023
21 Aug
OTC Application: 217780

Drug Name

GUAIFENESIN

Product Number

2

Dosage Form

-

Strength

1.2GM

Approval Date

2023-08-21

217780 / 2

Active Ingredient

GUAIFENESIN

Application Number

217780

Product Number

2

Dosage Form

-

Strength

1.2GM

Approval Date

2023-08-21

Regulatory Status

OTC

2009
26 Jun
OTC Application: 79205

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

EQ 200MG FREE ACID AND POTASSIUM SALT

Approval Date

2009-06-26

79205 / 1

Active Ingredient

IBUPROFEN

Application Number

79205

Product Number

1

Dosage Form

-

Strength

EQ 200MG FREE ACID AND POTASSIUM SALT

Approval Date

2009-06-26

Regulatory Status

OTC

2010
21 Dec
RX Application: 90796

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2010-12-21

90796 / 1

Active Ingredient

IBUPROFEN

Application Number

90796

Product Number

1

Dosage Form

-

Strength

400MG

Approval Date

2010-12-21

Regulatory Status

RX

2010
21 Dec
RX Application: 90796

Drug Name

IBUPROFEN

Product Number

2

Dosage Form

-

Strength

600MG

Approval Date

2010-12-21

90796 / 2

Active Ingredient

IBUPROFEN

Application Number

90796

Product Number

2

Dosage Form

-

Strength

600MG

Approval Date

2010-12-21

Regulatory Status

RX

2010
21 Dec
RX Application: 90796

Drug Name

IBUPROFEN

Product Number

3

Dosage Form

-

Strength

800MG

Approval Date

2010-12-21

90796 / 3

Active Ingredient

IBUPROFEN

Application Number

90796

Product Number

3

Dosage Form

-

Strength

800MG

Approval Date

2010-12-21

Regulatory Status

RX

2011
08 Feb
OTC Application: 91237

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2011-02-08

91237 / 1

Active Ingredient

IBUPROFEN

Application Number

91237

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2011-02-08

Regulatory Status

OTC

2011
01 Feb
OTC Application: 91239

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2011-02-01

91239 / 1

Active Ingredient

IBUPROFEN

Application Number

91239

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2011-02-01

Regulatory Status

OTC

2025
17 Nov
OTC Application: 220153

Drug Name

LOPERAMIDE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2025-11-17

220153 / 1

Active Ingredient

LOPERAMIDE HYDROCHLORIDE

Application Number

220153

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2025-11-17

Regulatory Status

OTC

2016
23 Sep
OTC Application: 206214

Drug Name

LORATADINE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2016-09-23

206214 / 1

Active Ingredient

LORATADINE

Application Number

206214

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2016-09-23

Regulatory Status

OTC

2024
21 Nov
OTC Application: 219223

Drug Name

LORATADINE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2024-11-21

219223 / 1

Active Ingredient

LORATADINE

Application Number

219223

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2024-11-21

Regulatory Status

OTC

2016
29 Apr
RX Application: 90295

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2016-04-29

90295 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

90295

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2016-04-29

Regulatory Status

RX

2016
29 Apr
RX Application: 90295

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2016-04-29

90295 / 2

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

90295

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2016-04-29

Regulatory Status

RX

2012
12 Mar
RX Application: 90888

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2012-03-12

90888 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

90888

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2012-03-12

Regulatory Status

RX

2012
12 Mar
RX Application: 90888

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

850MG

Approval Date

2012-03-12

90888 / 2

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

90888

Product Number

2

Dosage Form

-

Strength

850MG

Approval Date

2012-03-12

Regulatory Status

RX

2012
12 Mar
RX Application: 90888

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

1GM

Approval Date

2012-03-12

90888 / 3

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

90888

Product Number

3

Dosage Form

-

Strength

1GM

Approval Date

2012-03-12

Regulatory Status

RX

2011
16 Mar
OTC Application: 90545

Drug Name

NAPROXEN SODIUM

Product Number

1

Dosage Form

-

Strength

220MG

Approval Date

2011-03-16

90545 / 1

Active Ingredient

NAPROXEN SODIUM

Application Number

90545

Product Number

1

Dosage Form

-

Strength

220MG

Approval Date

2011-03-16

Regulatory Status

OTC

2025
07 Aug
OTC Application: 218829

Drug Name

OMEPRAZOLE MAGNESIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2025-08-07

218829 / 1

Active Ingredient

OMEPRAZOLE MAGNESIUM

Application Number

218829

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2025-08-07

Regulatory Status

OTC

2016
07 Oct
RX Application: 204948

Drug Name

PARICALCITOL

Product Number

1

Dosage Form

-

Strength

1MCG

Approval Date

2016-10-07

204948 / 1

Active Ingredient

PARICALCITOL

Application Number

204948

Product Number

1

Dosage Form

-

Strength

1MCG

Approval Date

2016-10-07

Regulatory Status

RX

2016
07 Oct
RX Application: 204948

Drug Name

PARICALCITOL

Product Number

2

Dosage Form

-

Strength

2MCG

Approval Date

2016-10-07

204948 / 2

Active Ingredient

PARICALCITOL

Application Number

204948

Product Number

2

Dosage Form

-

Strength

2MCG

Approval Date

2016-10-07

Regulatory Status

RX

2016
07 Oct
RX Application: 204948

Drug Name

PARICALCITOL

Product Number

3

Dosage Form

-

Strength

4MCG

Approval Date

2016-10-07

204948 / 3

Active Ingredient

PARICALCITOL

Application Number

204948

Product Number

3

Dosage Form

-

Strength

4MCG

Approval Date

2016-10-07

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    38 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
38 total
  • OTC
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACETAMINOPHEN

Application Number

215486

Product Number

1

Active Ingredient

ACETAMINOPHEN

Dosage Form

-

Strength

650MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit